ETV2 regulates PARP-1 binding protein to induce ER stress–mediated death in tuberin-deficient cells
暂无分享,去创建一个
Abhijeet R. Sonawane | W. Qiu | E. Henske | J. Moss | K. Tantisira | A. Sonawane | K. Glass | S. El-Chemaly | H. Christou | M. Perrella | Xiaoli Liu | A. Hentschel | W. Steagall | G. Pacheco‐Rodriguez | Kosmas Kosmas | J. Imani | Pierce H. Louis | S. Shrestha | Julie Ng | Anthony M Lamattina | R. Onishi | Shikshya Shrestha
[1] B. Nadler,et al. Zero-preserving imputation of single-cell RNA-seq data , 2022, Nature Communications.
[2] P. Anderson,et al. TSC2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation , 2021, Molecular Cancer Research.
[3] W. McDonnell,et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. , 2020, Science advances.
[4] D. Kwiatkowski,et al. Single Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell. , 2020, American journal of respiratory and critical care medicine.
[5] Weihong Zhang,et al. Lymphangioleiomyomatosis , 2020, Seminars in Respiratory and Critical Care Medicine.
[6] Yue Hao,et al. clustifyr: an R package for automated single-cell RNA sequencing cluster classification , 2019, bioRxiv.
[7] J. Kim,et al. ETV2/ER71 regulates the generation of FLK1+ cells from mouse embryonic stem cells through miR-126-MAPK signaling , 2019, Stem Cell Research & Therapy.
[8] Dong Hun Lee,et al. ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease , 2019, Theranostics.
[9] W. Gong,et al. Etv2 transcriptionally regulates Yes1 and promotes cell proliferation during embryogenesis , 2019, Scientific Reports.
[10] M. O’Connor,et al. PARI (PARPBP) suppresses replication stress-induced myeloid differentiation in leukemia cells , 2019, Oncogene.
[11] Changhua Wang,et al. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma , 2019, Digestive Diseases and Sciences.
[12] Fan Zhang,et al. Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.
[13] Sojin Park,et al. Spleen tyrosine kinase-dependent Nrf2 activation regulates oxidative stress-induced cell death in WiL2-NS human B lymphoblasts , 2018, Free radical research.
[14] Kyunghee Choi,et al. ETS transcription factor Etsrp / Etv2 is required for lymphangiogenesis and directly regulates vegfr3 / flt4 expression. , 2018, Developmental biology.
[15] Jeffrey C. Berry,et al. Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis. , 2018, JCI insight.
[16] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[17] Shuo Lin,et al. ETV2 mediates endothelial transdifferentiation of glioblastoma , 2018, Signal Transduction and Targeted Therapy.
[18] R. Janknecht,et al. Cooperation between ETS variant 2 and Jumonji domain-containing 2 histone demethylases , 2018, Molecular medicine reports.
[19] Evan Bolton,et al. Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..
[20] E. Henske,et al. Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. , 2017, Cancer research.
[21] P. Ashton-Prolla,et al. TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review , 2017, Genetics and molecular biology.
[22] E. Henske,et al. Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis. , 2016, The American journal of pathology.
[23] Szilvia Juhász,et al. The PCNA-associated protein PARI negatively regulates homologous recombination via the inhibition of DNA repair synthesis , 2016, Nucleic acids research.
[24] M. Kirpichnikov,et al. PARP1 Inhibitors: antitumor drug design , 2015, Acta naturae.
[25] Daofeng Li,et al. Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2 , 2015, EMBO reports.
[26] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[27] Jianhua Yao,et al. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. , 2014, American journal of respiratory and critical care medicine.
[28] A. Chinnaiyan,et al. Molecular Pathways: Targeting ETS Gene Fusions in Cancer , 2014, Clinical Cancer Research.
[29] J. Shelton,et al. Fli1 Acts Downstream of Etv2 to Govern Cell Survival and Vascular Homeostasis via Positive Autoregulation , 2014, Circulation research.
[30] J. Moss,et al. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. , 2013, The American journal of pathology.
[31] C. Huttenhower,et al. Passing Messages between Biological Networks to Refine Predicted Interactions , 2013, PloS one.
[32] A. Husain,et al. Lymphatic Endothelial Differentiation in Pulmonary Lymphangioleiomyomatosis Cells , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[33] A. D’Andrea,et al. PARI overexpression promotes genomic instability and pancreatic tumorigenesis. , 2013, Cancer research.
[34] L. Varışlı. Meta-analysis of the cell cycle related C12orf48. , 2013, Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al.
[35] K. Ross,et al. SYK Regulates mTOR Signaling in AML , 2013, Leukemia.
[36] W. Tao,et al. Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit* , 2013, The Journal of Biological Chemistry.
[37] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology Information , 2012, Nucleic Acids Res..
[38] F. Uckun,et al. Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros , 2012, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Laurent,et al. Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis , 2012, Leukemia.
[40] S. Nishikawa,et al. PKA/CREB Signaling Triggers Initiation of Endothelial and Hematopoietic Cell Differentiation via Etv2 Induction , 2012, Stem cells.
[41] C. Burger. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. , 2011, The New England journal of medicine.
[42] Yusuke Nakamura,et al. C12orf48, termed PARP‐1 binding protein, enhances poly(ADP‐ribose) polymerase‐1 (PARP‐1) activity and protects pancreatic cancer cells from DNA damage , 2011, Genes, chromosomes & cancer.
[43] W. Linehan,et al. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. , 2010, Chest.
[44] Andrew R. Gehrke,et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo , 2010, The EMBO journal.
[45] G. Oliver,et al. Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell , 2010, Development.
[46] Mikael Bodén,et al. MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..
[47] E. Henske,et al. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells , 2009, Proceedings of the National Academy of Sciences.
[48] J. Moss,et al. Lymphatic Involvement in Lymphangioleiomyomatosis , 2008, Annals of the New York Academy of Sciences.
[49] M. Sahin,et al. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. , 2008, Molecular cell.
[50] J. Moss,et al. TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis. , 2007, Cancer research.
[51] G. Laurent,et al. Syk-dependent mTOR activation in follicular lymphoma cells. , 2006, Blood.
[52] Y. Fukuchi,et al. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis. , 2006, Lymphatic research and biology.
[53] R. Myers,et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.
[54] N. Sidell,et al. Growth‐related oncogene produced in human breast cancer cells and regulated by Syk protein‐tyrosine kinase , 2005, International journal of cancer.
[55] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[56] Jerilyn A. Walker,et al. Quantitative PCR for DNA identification based on genome-specific interspersed repetitive elements. , 2004, Genomics.
[57] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[58] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[59] D. Kwiatkowski,et al. Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation , 2002, The Journal of Biological Chemistry.
[60] D. Kwiatkowski,et al. Molecular genetic advances in tuberous sclerosis , 2000, Human Genetics.
[61] E. Henske,et al. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[62] D. Garry. Etv2 IS A MASTER REGULATOR OF HEMATOENDOTHELIAL LINEAGES. , 2016, Transactions of the American Clinical and Climatological Association.
[63] E. Roach,et al. Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.
[64] K. Guan,et al. The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis , 2011, Cell Death and Differentiation.
[65] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[66] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[67] P. Anderson,et al. Stressful initiations. , 2002, Journal of cell science.
[68] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .